InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Bermingham Nessan. Director active across 2 companies, notably F-star Therapeutics, Inc.. In total, 4 filings have been logged. Activity tracked since 20 November 2020. The latest transaction was disclosed on 8 March 2023 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
35,114 sharesCommon StockSEC:0000950170-23-060608:0
97,547 shares@ US$7.12100.0% of flowCommon StockSEC:0000899243-23-007657:0
16,875 shares0Common StockSEC:0001209191-21-053233:0
16,875 shares0Common StockSEC:0001209191-21-053233
4 of 4 declarations
About Bermingham Nessan
Bermingham Nessan is a declarant and a director at F-star Therapeutics, Inc. and Korro Bio, Inc. The 4 filings in the recent sample cover the period from 2021-08-24 to 2023-11-07, with the transaction nature listed as Attribution. Buy and sell amounts are both EUR 0; among the main filings are EUR 658279.9193932532 on 2023-03-09 at F-star Therapeutics, Inc., a 2023-11-07 filing at Korro Bio, Inc. with no amount stated, and two 2021-08-24 filings at F-star Therapeutics, Inc. at EUR 0.
